Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2740
Nomenclature: SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4
Abbreviated Name: SMARCA4
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1647 | 19p13.2 | SMARCA4 | SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | |
Mouse | - | 1613 | 9 7.84 cM | Smarca4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | |
Rat | - | 1613 | 8q13 | Smarca4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
Previous and Unofficial Names |
BAF190 | SNF2-BETA | SWI2 | SWI/SNF related | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
Database Links | |
Alphafold | P51532 (Hs), Q3TKT4 (Mm) |
CATH/Gene3D | 1.20.920.10 |
ChEMBL Target | CHEMBL3085620 (Hs) |
Ensembl Gene | ENSG00000127616 (Hs), ENSMUSG00000032187 (Mm), ENSRNOG00000009271 (Rn) |
Entrez Gene | 6597 (Hs), 20586 (Mm), 171379 (Rn) |
Human Protein Atlas | ENSG00000127616 (Hs) |
KEGG Gene | hsa:6597 (Hs), mmu:20586 (Mm), rno:171379 (Rn) |
OMIM | 603254 (Hs) |
Pharos | P51532 (Hs) |
RefSeq Nucleotide | NM_001128849 (Hs), NM_001174078 (Mm), NM_134368 (Rn) |
RefSeq Protein | NP_001122321 (Hs), NP_001167549 (Mm), NP_599195 (Rn) |
SynPHARM | 80802 (in complex with PFI-3) |
UniProtKB | P51532 (Hs), Q3TKT4 (Mm) |
Wikipedia | SMARCA4 (Hs) |
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Other Binding Ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
||
|
||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||
|
||||||||||||
|
||||||||||||
|
1. Cantley J, Ye X, Rousseau E, Januario T, Hamman BD, Rose CM, Cheung TK, Hinkle T, Soto L, Quinn C et al.. (2022) Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers. Nat Commun, 13 (1): 6814. [PMID:36357397]
2. SGC. PFI-3 A Selective chemical probe for SMARCA bromodomains. Accessed on 10/11/2014. Modified on 04/08/2023. thesgc.org, https://www.thesgc.org/chemical-probes/PFI-3
3. Taylor AM, Bailey C, Belmont LD, Campbell R, Cantone N, Côté A, Crawford TD, Cummings R, DeMent K, Duplessis M et al.. (2022) GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1. J Med Chem, 65 (16): 11177-11186. [PMID:35930799]
4. Yang L, Tu W, Huang L, Miao B, Kaneshige A, Jiang W, Leng L, Wang M, Wen B, Sun D et al.. (2023) Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity. J Med Chem, 66 (15): 10761-10781. [PMID:37523716]
Non-enzymatic BRD containing proteins: SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4. Last modified on 01/10/2024. Accessed on 11/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2740.